Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Alopecia areata affects quality of life more in adolescents than adults.

Combining fractional CO2 laser with halometasone cream is more effective for chronic eczema than the cream alone.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.